<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04397354</url>
  </required_header>
  <id_info>
    <org_study_id>2</org_study_id>
    <nct_id>NCT04397354</nct_id>
  </id_info>
  <brief_title>Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells</brief_title>
  <official_title>Intracochlear Dexamethasone Application During Cochlear Implantation for Preserving Cochlear Cells</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pamukkale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pamukkale University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The protection of cochlear cells is one of the main concerns of cochlear implant surgery. New
      electrode designs or additional molecules have been used for this purpose. The aim of the
      study is to test the effect of dexamethasone in two different application methods.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The protection of cochlear cells is one of the main concerns of cochlear implant surgery. New
      electrode designs or additional molecules have been used for this purpose. The aim of the
      study is to test the effect of dexamethasone in two different application methods.
      Participants who will have cochlear implant surgery will be divided into three groups. Group
      1 will have intracochlear dexamethasone after the incision of the round window membrane.
      Group 2 will have intratympanic dexamethasone after the incision of the round window
      membrane. Group 3 will serve as a control group. All participants will be tested after a
      week, a month, 3, and 6 months. Impedance and threshold measurements will be compared.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 2, 2020</start_date>
  <completion_date type="Anticipated">November 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective, randomized</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Electrode Impedance(Ohm)</measure>
    <time_frame>1-3 months</time_frame>
    <description>All intra-operative impedance values will be acquired after surgery. They will be repeated in first and 3 rd months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Electrode thresholds(CL)</measure>
    <time_frame>1-3 months</time_frame>
    <description>All intra-operative thresholds will be acquired after surgery. They will be repeated in first and 3 rd months</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Hearing Loss, Sensorineural</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intracochlear dexamethasone application during cochlear implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>intratympanic dexamethasone application during cochlear implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>No drugs during cochlear implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intracochlear Dexamethasone</intervention_name>
    <description>intracochlear injection of dexamethasone with cochlear implantation</description>
    <arm_group_label>Group 1</arm_group_label>
    <other_name>intracochlear</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intratympanic Dexamethasone</intervention_name>
    <description>intratympanic injection of dexamethasone with cochlear implantation</description>
    <arm_group_label>Group 2</arm_group_label>
    <other_name>intratympanic</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>No additional drugs(control Group)</intervention_name>
    <description>Control group: No drugs will be injected middle ear with cochlear implantation</description>
    <arm_group_label>Group 3</arm_group_label>
    <other_name>No drugs</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with sensorineural hearing loss

          -  Patients who will have cochlear implant surgery with CI422 electrode

        Exclusion Criteria:

          -  Patients with cochlear abnormality

          -  Patients with auditory neuropathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fazil N Ardic, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pamukkale University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Pamukkale University</name>
      <address>
        <city>Denizli</city>
        <zip>20070</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 13, 2020</study_first_submitted>
  <study_first_submitted_qc>May 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>May 21, 2020</last_update_submitted>
  <last_update_submitted_qc>May 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pamukkale University</investigator_affiliation>
    <investigator_full_name>Fazıl Necdet Ardıç</investigator_full_name>
    <investigator_title>Prof.Dr.</investigator_title>
  </responsible_party>
  <keyword>cochlear implant</keyword>
  <keyword>dexamethasone</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The metadata will be shared by a public depository.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

